BoneScreen | Disease detection | Digital biomarkers | AI
Bonescreen is a TU Münich spin-out company enabling opportunistic disease detection” of patients CT-scan for additional diseases. bonescreen’s identified digital biomarkers combined with AI-supported analysis tools detect early stages of osteoporosis. Bonescreen enables early diagnosis and early therapeutic treatment – with higher probability of best clinical outcome for patients.
We defined core tasks and addressed them in prepared team coaching / workshop sessions:
- Commercial Strategy and Business model development
- IP Strategy development
- HCP stakeholder identification and engagement
- Review of soft-funding grant applications
- Selecting key profiles for Board of Directors
Bonescreen is part of the EIT Health Wild Card programme. Bonescreen’s founders selected me as Lead Mentor, with weekly mentoring sessions.